Core A: Administrative Core

核心A：行政核心

• 批准号: 9071064
• 负责人: James Brugarolas
• 金额: $ 16.33万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9071064
• 关键词: Adherence; Advocate; Awareness; Basic Science; Biometry; Cancer Biology; Cancer Center; Cancer Patient; Caring; Clinical; Clinical Research; Common Neoplasm; Communication; Complement; Complex; County Hospitals; Data Analytics; Development; Disputes; Ensure; Epidemiology; Event; Faculty; Faculty Recruitment; Funding; Grant; Hispanics; Hospitals; Incidence; Individual; K-Series Research Career Programs; Laboratories; Leadership; Medical center; Mission; Monitor; Operative Surgical Procedures; Patient advocacy; Patients; Qualifying; Recording of previous events; Regulation; Renal carcinoma; Reporting; Research; Research Personnel; Resolution; Resource Allocation; Resource Sharing; Role; Schedule; Science; Services; Texas; Translating; Translational Research; Underserved Population; Universities; University Hospitals; Urology; Wages; Woman; biomedical informatics; career; cost; data management; experience; indexing; medical schools; meetings; member; outreach; professor; programs; social; volunteer

Project Summary This core will provide essential administrative services and support for the UTSW Kidney Cancer SPORE. The PI, Dr. Brugarolas, is well-suited to provide overall direction, facilitate interactions, provide scientific leadership, and oversee the fiscal management of this complex grant. His scientific background, history of participation in many aspects of translational science, and current administrative roles at UTSW (including Leader of the Kidney Cancer Program (KCP) and member of the scientific leadership of the NCI-designated, now comprehensive, Simmons Cancer Center) make him well-qualified to serve as overall PI and Core Director. He is aided by Core A Co-Directors, Dr. Sagalowsky (Professor of Urology and Surgery, and a KCP Urology co-Leader), and Dr. McKay (KCP Director of Research Administration), and a first-rate administrative team. An Executive Committee (Project Leaders and Core Directors) provides advice for the planning of SPORE strategic directions, interactions with departments and administration, faculty recruitment, and resource allocation. The KCP and SPORE are well-integrated within the Cancer Center and benefit from many shared resources. Institutional commitment is illustrated by (i) participation in the IAB of outstanding investigators and institutional leaders, and (ii) a significant financial commitment, including $1,100,000 in annual direct support for salaries, benefits and operating costs of key investigators and their laboratories, and recurring annual funds of: $150,000 (to match CEP and DRP), $150,000 (to support the Data Analytics Core), and $50,000 (discretionary funds). In addition, $1,100,000 in recruitment funds will be made available. The SPORE includes a dynamic patient advocacy team of engaged individuals who have participated extensively in the KCP, including fundraising, raising awareness, and social events. Our outstanding EAB includes leaders in their fields with complementary expertise in clinical/translational research (Arteaga, George, Michaelson, Nelson, Oh, Ratain, and Shyr), epidemiological research (Heng and Shyr), and basic research (Simon). The Core A aims are straightforward and should fulfill the objective of organizing a complex network of interactions involving numerous investigators, staff, cores, and advocates: (1) Oversee and direct all scientific and administrative aspects of the SPORE including research/data management, fiscal oversight and adherence, and communication aspects: (a) Oversee and maintain scientific quality and rigor of the SPORE; (b) Record, monitor, and oversee all budgetary items; (c) Monitor and ensure all aspects of SPORE compliance following NCI regulations and requirements, and communicate with NCI Program Officer (and other staff) to ensure compliance with reporting; (d) Schedule and organize all meetings, including meetings with the Advisory Boards, and Patient Advocates. (2) Oversee and coordinate with the Developmental Research Program and the Career Enhancement Program to provide fiscal, organizational, and outreach support. (3) Coordinate and oversee Patient Advocate Program activities. (4) Oversee and facilitate resolution of scientific disputes.

项目摘要 该核心将为UTSW肾脏癌孢子提供基本的行政服务和支持。 Brugarolas博士非常适合提供整体方向，促进互动，提供科学 领导，并监督这项复杂赠款的财政管理。他的科学背景，历史 参与转化科学的许多方面，以及UTSW的当前行政角色（包括 肾脏癌症计划（KCP）的负责人和NCI指定的科学领导成员， 现在是全面的，西蒙斯癌症中心）使他合格地担任整体PI和核心 导演。他得到了核心联合指导者Sagalowsky博士（泌尿外科和外科教授和KCP）的帮助 泌尿外科联合领导者）和麦凯博士（KCP研究管理局主任）和一流的行政 团队。执行委员会（项目负责人和核心董事）为计划提供建议 孢子战略方向，与部门和行政部门的互动，教职员工招聘以及 资源分配。 KCP和孢子在癌症中心良好整合，并受益于许多 共享资源。 （i）参与杰出的IAB来说明机构承诺 调查人员和机构领导人，以及（ii）一项重大财务承诺，包括1,100,000美元 年度直接支持主要调查员及其实验室的薪水，福利和运营成本，以及 经常出现的年度资金：150,000美元（与CEP和DRP相匹配），150,000美元（支持数据分析核心）， 和50,000美元（可支配基金）。此外，还将提供1,100,000美元的招聘资金。这 孢子包括一个充满广泛参与的人的动态患者倡导团队 KCP，包括筹款，提高认识和社交活动。我们杰出的EAB包括 他们的领域具有临床/翻译研究中的补充专业知识（Arteaga，George，Michaelson， 俄亥俄州尼尔森，比塔因和史尔），流行病学研究（亨和谢尔）以及基础研究（Simon）。这 核心A目标很简单，应该实现组织复杂互动网络的目标 涉及众多调查员，员工，核心和倡导者：（1）监督和指导所有科学和 孢子的行政方面，包括研究/数据管理，财政监督和依从性， 和沟通方面：（a）监督和维持孢子的科学质量和严格； （b）记录， 监视并监督所有预算项目； （c）监视并确保孢子合规性的各个方面 NCI法规和要求，并与NCI计划官员（和其他工作人员）进行沟通，以确保 遵守报告； （d）安排并组织所有会议，包括与咨询会议 董事会和患者拥护者。 （2）监督并与发展研究计划和协调 提供财政，组织和外展支持的职业增强计划。 （3）协调和 监督患者倡导计划活动。 （4）监督和促进科学纠纷的解决。